113 related articles for article (PubMed ID: 7844914)
1. [Detection of intratumoral DNA heterogeneity in primary lung cancer using a multiple sampling method].
Mizobuchi K; Fujita Y; Hashikura H; Arimoto T; Nakagaki Y; Goto T; Fujii T; Iwasaki Y; Nakamura T; Nakagawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Oct; 32(10):963-9. PubMed ID: 7844914
[TBL] [Abstract][Full Text] [Related]
2. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers.
Furuya T; Uchiyama T; Murakami T; Adachi A; Kawauchi S; Oga A; Hirano T; Sasaki K
Clin Cancer Res; 2000 Jul; 6(7):2815-20. PubMed ID: 10914729
[TBL] [Abstract][Full Text] [Related]
3. In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers.
Simony J; Pujol JL; Radal M; Ursule E; Michel FB; Pujol H
Cancer Res; 1990 Jul; 50(14):4382-7. PubMed ID: 2163748
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics and problems of flow cytometric nuclear DNA content analysis in lung cancer using bronchoscopically-obtained specimens].
Ariyoshi I
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1704-10. PubMed ID: 1333022
[TBL] [Abstract][Full Text] [Related]
6. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up].
Nagai S; Chiba W; Ikeda S; Matsumoto H; Fujimoto T; Ishida H; Wazawa H; Hanawa T; Yamashita N; Yasuda Y; Matsubara Y; Hatakenaka R; Funatsu T
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():130-4. PubMed ID: 8678555
[TBL] [Abstract][Full Text] [Related]
8. [DNA content analysis and detection of c-myc and p53 products using flow cytometry in resected lung cancer cases].
Chiba W; Sawai S; Ikeda S; Morimoto K; Wazawa H; Hanawa T; Yamashita N; Matsui T; Hatakenaka R; Matsubara Y
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():108-16. PubMed ID: 8203922
[TBL] [Abstract][Full Text] [Related]
9. [Flow cytometric analysis of DNA content in lung cancer].
Liu GX
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Oct; 15(5):290-2, 320. PubMed ID: 1339110
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of flow cytometry in squamous cell bronchogenic cancer. A retrospective study of 61 cases].
Jeanfaivre T; Chassevent A; Geslin J; Larra F; Tuchais E
Bull Cancer; 1997 Jun; 84(6):597-602. PubMed ID: 9295862
[TBL] [Abstract][Full Text] [Related]
11. The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometry.
Stipa S; Danesi DT; Modini C; Cicconetti F; Mauro F; Schillaci A; Mecozzi A; Nicolanti V; Stipa F; Mancini M
Surg Gynecol Obstet; 1993 May; 176(5):427-34. PubMed ID: 8386859
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral heterogeneity of DNA ploidy in breast carcinomas: a flow cytometric assessment of sampling techniques.
Schvimer M; Lash RH; Katzin WE
Cytometry; 1995 Dec; 22(4):292-6. PubMed ID: 8749779
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral heterogeneity in colorectal carcinoma: trucut sampling for DNA ploidy analysis.
Giovagnoli MR; Giarnieri E; Midiri G; Tesoriere A; Ferraro S; Vecchione A
Anticancer Res; 1999; 19(5C):4577-80. PubMed ID: 10650813
[TBL] [Abstract][Full Text] [Related]
14. Synchronous lung cancers defined by deoxyribonucleic acid flow cytometry.
Ichinose Y; Hara N; Ohta M
J Thorac Cardiovasc Surg; 1991 Sep; 102(3):418-24. PubMed ID: 1652669
[TBL] [Abstract][Full Text] [Related]
15. [DNA flow cytometry in the prognostication of certain malignant neoformations].
Nikolaeva TG; Dobrynin IaV; Akhundov AA; Prorokov VV; Davydov MI
Vopr Onkol; 2001; 47(6):684-9. PubMed ID: 11826489
[TBL] [Abstract][Full Text] [Related]
16. DNA distribution in non-small-cell lung carcinomas and its relationship to clinical behavior.
Volm M; Mattern J; Sonka J; Vogt-Schaden M; Wayss K
Cytometry; 1985 Jul; 6(4):348-56. PubMed ID: 2990835
[TBL] [Abstract][Full Text] [Related]
17. [Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature].
Jeanfaivre T; Chassevent A; Larra F; Tuchais E
Bull Cancer; 1994 Jul; 81(7):605-9. PubMed ID: 7742603
[TBL] [Abstract][Full Text] [Related]
18. Intracellular pH, esterase activity, and DNA measurements of human lung carcinomas by flow cytometry.
Liewald F; Demmel N; Wirsching R; Kahle H; Valet G
Cytometry; 1990; 11(3):341-8. PubMed ID: 2340771
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of human lung cancer. Correlation with histologic type and stage.
Moran RE; Melamed MR
Anal Quant Cytol; 1984 Jun; 6(2):99-104. PubMed ID: 6205621
[TBL] [Abstract][Full Text] [Related]
20. Stemline heterogeneity of nuclear DNA in hepatocellular carcinoma.
Iwao Y; Kim YI; Kaketani K; Nakashima K; Okada K; Kobayashi M
Hepatogastroenterology; 1993 Oct; 40(5):491-5. PubMed ID: 8270242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
